BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

165 related articles for article (PubMed ID: 10637198)

  • 21. Cardiac effects of iodixanol compared to those of other nonionic and ionic contrast media on the isolated rat heart.
    Dunkel JA; Bokenes J; Karlsson JO; Refsum H
    Acta Radiol Suppl; 1995; 399():142-54. PubMed ID: 8610508
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Iopromide, a new contrast medium for angiography. Clinical study and comparison with other low-osmolar contrast media].
    Steidle B; Wolf KJ; Banzer D; Seyferath W
    Dtsch Med Wochenschr; 1984 Aug; 109(34):1275-8. PubMed ID: 6381018
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Evaluation of ketanserin in the prevention of restenosis after percutaneous transluminal coronary angioplasty. A multicenter randomized double-blind placebo-controlled trial.
    Serruys PW; Klein W; Tijssen JP; Rutsch W; Heyndrickx GR; Emanuelsson H; Ball SG; Decoster O; Schroeder E; Liberman H
    Circulation; 1993 Oct; 88(4 Pt 1):1588-601. PubMed ID: 8403306
    [TBL] [Abstract][Full Text] [Related]  

  • 24. N-acetylcysteine does not prevent contrast induced nephropathy after cardiac catheterisation with an ionic low osmolality contrast medium: a multicentre clinical trial.
    Gomes VO; Poli de Figueredo CE; Caramori P; Lasevitch R; Bodanese LC; Araújo A; Röedel AP; Caramori AP; Brito FS; Bezerra HG; Nery P; Brizolara A
    Heart; 2005 Jun; 91(6):774-8. PubMed ID: 15894775
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Iodixanol in cardioangiography in patients with coronary artery disease. Tolerability, cardiac and renal effects.
    Kløw NE; Levorstad K; Berg KJ; Brodahl U; Endresen K; Kristoffersen DT; Laake B; Simonsen S; Tofte AJ; Lundby B
    Acta Radiol; 1993 Jan; 34(1):72-7. PubMed ID: 8427753
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Are ioxaglate and iopamidol equally safe and well tolerated in cardiac angiography? A randomized, double-blind clinical study.
    Piscione F; Focaccio A; Santinelli V; De Paola M; Villari B; Spinazzi A; Condorelli M; Chiariello M
    Am Heart J; 1990 Nov; 120(5):1130-6. PubMed ID: 2239665
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Nonionic contrast media. Procoagulants or clotting innocents?
    Grabowski EF; Head C; Michelson AD
    Invest Radiol; 1993 Nov; 28 Suppl 5():S21-4. PubMed ID: 8282498
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Influence of contrast media on thrombus formation during coronary angioplasty.
    Gasperetti CM; Feldman MD; Burwell LR; Angello DA; Haugh KH; Owen RM; Powers ER
    J Am Coll Cardiol; 1991 Aug; 18(2):443-50. PubMed ID: 1856412
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Platelet degranulation induced by some contrast media is independent of their nonionic vs ionic nature.
    Grabowski EF; Jang IK; Gold H; Palacios IF; Boor SE; Rodino LJ; Michelson AD
    Acta Radiol Suppl; 1995; 399():182-4. PubMed ID: 8610512
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Profound platelet degranulation is an important side effect of some types of contrast media used in interventional cardiology.
    Chronos NA; Goodall AH; Wilson DJ; Sigwart U; Buller NP
    Circulation; 1993 Nov; 88(5 Pt 1):2035-44. PubMed ID: 8222096
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Influence of low osmolality contrast media on electrophysiology and hemodynamics in coronary angiography: differences between an ionic (ioxaglate) and a nonionic (iohexol) agent.
    Vik-Mo H; Følling M; Barth P; Nordrehaug JE; Bjørkhaug A; Rosland GA
    Cathet Cardiovasc Diagn; 1990 Dec; 21(4):221-6. PubMed ID: 2276191
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Effect on thrombus growth and thrombolysis of two types of osmolar contrast media in rabbits.
    Levi M; Pascucci C; Agnelli G; Sturk A; Hoek J; Wouter ten Cate J
    Invest Radiol; 1990 May; 25(5):533-5. PubMed ID: 2345084
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Safety and tolerability of iodixanol in healthy volunteers with reference to two monomeric X-ray contrast media.
    Jørgensen NP; Nossen JO; Borch KW; Kristiansen AB; Kristoffersen DT; Lundby B; Theodorsen L
    Eur J Radiol; 1992 Oct; 15(3):252-7. PubMed ID: 1490453
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Iso-Osmolar Iodixanol Induces Less Increase in Circulating Endothelial Microparticles
    Zhang B; Zhang Y; Liu B; Fang L; Li Y; Meng S
    Contrast Media Mol Imaging; 2018; 2018():8303609. PubMed ID: 29849514
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Aortocervical angiography with high and low osmolality ionic contrast media. A clinical investigation of metrizoate and ioxaglate.
    Nilsson PE; Aspelin P; Elmquist D
    Acta Radiol Diagn (Stockh); 1985; 26(6):731-8. PubMed ID: 3909752
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Iodixanol, a new isosmotic nonionic contrast agent compared with iohexol in cardiac angiography.
    Hill JA; Cohen MB; Kou WH; Mancini GB; Mansour M; Fountaine H; Brinker JA
    Am J Cardiol; 1994 Jul; 74(1):57-63. PubMed ID: 8017308
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Iohexol, ioxaglate and iopamidol in coronary angiography. A double-blind comparative study of 300 patients.
    Soiva M; Hekali P; Keto P; Karumo J; Salonen O; Heikkilä J
    Australas Radiol; 1991 May; 35(2):109-11. PubMed ID: 1930006
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Oxygen saturation of the low osmolar contrast media iohexol, ioxaglate and iodixanol. Effects on contractile force and frequency of ventricular fibrillation in the isolated rabbit heart.
    Bååth L; Almén T; Oksendal A
    Acta Radiol; 1990 Sep; 31(5):519-23. PubMed ID: 2261303
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Comparison of angiographic opacification of ioxaglate and iodixanol by digital region-of-interest processing technique in an experimental circulation model.
    Yang X; Manninen H; Soimakallio S
    Invest Radiol; 1994 Jan; 29(1):31-4. PubMed ID: 8144334
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Iodixanol in femoral arteriography. A randomized, double-blind, phase III, parallel study with iodixanol 270 mg I/ml and iohexol 300 mg I/ml.
    Thorstensen O; Albrechtsson U; Calissendorff B; Lárusdóttir H; Norgren L; Tengvar M; Bolstad B; Aspelin P
    Acta Radiol; 1994 Nov; 35(6):629-31. PubMed ID: 7946690
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.